BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5808043)

  • 1. Prolonged observations on variations in the serum copper in Hodgkin's disease.
    Warren RL; Jelliffe AM; Watson JV; Hobbs CB
    Clin Radiol; 1969 Jul; 20(3):247-56. PubMed ID: 5808043
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 4. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceruloplasmin in Hodgkin's disease.
    Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
    Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpreting serum copper levels in Hodgkin's disease.
    Hrgovcic MJ; Tessmer CF; Mumford DM; Ong PS; Gamble JF; Shullenberger CC
    Tex Med; 1975 Feb; 71(2):53-63. PubMed ID: 1111152
    [No Abstract]   [Full Text] [Related]  

  • 7. Invited discussion: Value of fluctuations in the serum copper level in the control of patients with Hodgkin's disease.
    Jelliffe AM
    Natl Cancer Inst Monogr; 1973 May; 36():325-6. PubMed ID: 4744592
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963-1973.
    Thorling EB; Thorling K
    Cancer; 1976 Jul; 38(1):225-31. PubMed ID: 947517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of copper oxidase (ceruloplasmin) and related tests in Hodgkin's disease.
    Wolf PL; Ray G; Kaplan H
    Clin Biochem; 1979 Dec; 12(6):202-4. PubMed ID: 535145
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum copper in Hodgkin's disease in children.
    Tessmer CF; Hrgovcic M; Wilbur J
    Cancer; 1973 Feb; 31(2):303-15. PubMed ID: 4687877
    [No Abstract]   [Full Text] [Related]  

  • 13. Classification and prognostic value of serum copper/zinc ratio in Hodgkin's disease.
    Cunzhi H; Jiexian J; Xianwen Z; Jingang G; Suling H
    Biol Trace Elem Res; 2001 Nov; 83(2):133-8. PubMed ID: 11762530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
    Casamassima A; Addabbo L; Caporusso L; Lorusso V
    Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum copper in Hodgkin's disease: its relation to the anatomopathological variety, status and general signs].
    Aragón de la Cruz G; Otero Luna J; Criado Ortíz M; Polo Tolosana E
    Rev Clin Esp; 1975 Aug; 138(3):225-30. PubMed ID: 1178970
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of serum copper levels in adult patients with Hodgkin's disease.
    Hrgovcic M; Tessmer CF; Thomas FB; Fuller LM; Gamble JF; Shullenberger CC
    Cancer; 1973 Jun; 31(6):1337-45. PubMed ID: 4709950
    [No Abstract]   [Full Text] [Related]  

  • 17. Discriminant analysis of Hodgkin's disease and non-Hodgkin's lymphomas by age and serum proteins.
    Merucci P; Taggi F; Marolla A; Abbolito MR; Vitelli G; Marolla P; Meliffi L; Chiarotti F; Ippolito FM; Ameglio F
    Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1243-7. PubMed ID: 6567527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum copper levels in Hodgkin's disease].
    Cohen Y; Epelboim R; Haim N; Zinder O
    Harefuah; 1984 Mar; 106(6):252-4. PubMed ID: 6745761
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitro.
    Larsen B; Heron I; Thorling EB
    Eur J Cancer (1965); 1980 Mar; 16(3):415-21. PubMed ID: 6445273
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum complement level in Hodgkin's disease].
    Hamladji RM; Belhani M; Irunberry J; Benabadji M; Colonna P
    Nouv Rev Fr Hematol; 1972; 12(5):673-81. PubMed ID: 4120941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.